BGI and GE ally to further stem-cell derived assays
BGI has joined with GE Healthcare in a multi-year push to advance stem cell-derived assays for drug discovery and toxicology.
BGI has joined with GE Healthcare in a multi-year push to advance stem cell-derived assays for drug discovery and toxicology.
The CEO of Lycotec says its chocolate formulation of a liver-targeted oral compound has attracted interest from the NIH and FDA.